Original paper

BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation

Blood21.00
Volume: 130, Issue: 4, Pages: 489 - 500
Published: Jul 27, 2017
Abstract
Key Points A BCL2 IHC score is a strong prognostic factor independent of the IPI and MYC protein/rearrangement status in DLBCL treated with R-CHOP. The BCL2 scoring system we propose is a simple, at-a-glance, and highly reliable system, which was confirmed by an image...
Paper Details
Title
BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation
Published Date
Jul 27, 2017
Journal
Volume
130
Issue
4
Pages
489 - 500
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.